about
Review of antihemophilic factor injection for the routine prophylaxis of bleeding episodes and risk of joint damage in severe hemophilia A.The cost of severe haemophilia in Europe: the CHESS study.Mild hemophilia A.Practice of Iranian Adolescents with Hemophilia in Prevention of Complications of HemophiliaPrevalence, incidence, and factor concentrate usage trends of hemophiliacs in TaiwanThe management of hemophilia in elderly patients.Percutaneous coronary intervention in patients with haemophilia presenting with acute coronary syndrome: an interventional dilemma: case series, review of the literature, and tips for management.Cardiovascular disease prevalence and relevance in haemophilia: a scoping review.Neonatal Hemophilia: A Rare Presentation.Are haemophiliacs protected against cancer development? Prospective controlled studies are needed.Cancer detection and management in patients with haemophilia: a retrospective European multicentre study.Estimating unknown parameters in haemophilia using expert judgement elicitation.Experimental Validation of ARFI Surveillance of Subcutaneous Hemorrhage (ASSH) Using Calibrated Infusions in a Tissue-Mimicking Model and Dogs.Trunk muscle activation characteristics in patients with severe haemophilia.Retrospective analysis of 1,226 Chinese patients with haemophilia in a single medical centre.Healthcare resource utilization among haemophilia A patients in the United States.Management of Hemophilia in Older Patients.European principles of haemophilia care.Incidence, mortality rates and causes of deaths in haemophilia patients in Sweden.Haemophilia and joint disease: pathophysiology, evaluation, and management.
P2860
Q33715399-9432B67F-22C9-48ED-8886-CCBAE2678166Q33750095-668F087F-B5AD-423C-B6D2-554DE1E6A9EEQ34614695-9651D067-ACD2-4DBD-A0CA-D5C30FCB2391Q36196486-0FA8003F-0379-4825-9CC2-3432A49074DBQ36463984-176C8E31-8774-444E-9A03-AC3DC1673B0FQ37017437-A619F8C2-FCD7-4697-8DBC-548BAE58B767Q38041501-A1A2CB8B-8474-42D2-8E3E-A944A1C3E44EQ38270920-899E35E3-7042-4DB3-BA25-EF2EBDD3D65EQ42243561-3632B7C4-81A6-4805-9470-B6C1496FB943Q42344047-19B9AB23-6DEE-4F9D-9691-66AD258CAAB5Q43628424-49CF70C3-233B-4665-81D5-2EDB8FC6DB9BQ44008451-F1F34EAD-1320-4C5F-B512-579DED5C3473Q44861099-5674900E-63B0-444B-8916-465CDF2F9A10Q45856771-0AE18006-9F2D-40DC-9E08-79CC383B9967Q45857838-688AFD30-84B1-4D0E-A827-7B1C5361454EQ45874612-20490BF3-D1AF-4F34-9345-42334123C6FFQ45874801-14EAA2C6-83C7-47B9-8199-17B891F62FB0Q45874963-8EF452B0-F6E8-406A-BEF3-EFAA96AF4FD6Q45884712-69F6B8AE-DCD9-4CD3-B7D3-A9C69DD68F3FQ55004994-DEA92EAC-E605-4C71-992C-6C6CBB4209AF
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Life expectancy in hemophilia outcome.
@en
Life expectancy in hemophilia outcome.
@nl
type
label
Life expectancy in hemophilia outcome.
@en
Life expectancy in hemophilia outcome.
@nl
prefLabel
Life expectancy in hemophilia outcome.
@en
Life expectancy in hemophilia outcome.
@nl
P2093
P1476
Life expectancy in hemophilia outcome.
@en
P2093
Mejia-Carvajal C
Valentino LA
P2860
P304
P356
10.1111/J.1538-7836.2006.01776.X
P577
2006-03-01T00:00:00Z